NKGN

NKGen Biotech, Inc. Common Stock
NKGN

Overview Fund Activity
Delisted

NKGN was delisted on the 4th of March, 2025.

Back to rankings

25 hedge funds and large institutions have $5.07M invested in NKGen Biotech, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
25
Holders Change
+6
Holders Change %
+31.58%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
9
Increased
4
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Pathstone Holdings
1
Pathstone Holdings
New Jersey
$1.83M
2
MC
2
Meteora Capital
Florida
$1.82M
3
KC
3
Kepos Capital
New York
$151K
4
MF
4
Magnetar Financial
Illinois
$95.5K
5
SFA
5
Sequoia Financial Advisors
Ohio
$102K

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$0
2
UBS Group
2
UBS Group
Switzerland
$500
3
TRCT
3
Tower Research Capital (TRC)
New York
$1.82K
4
TCM
4
Towneley Capital Management
California
$0
5
HF
5
HRT Financial
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Citadel Advisors
26
Citadel Advisors
Florida
– – -95,438 Closed
HF
27
HRT Financial
New York
– – -10,318 Closed
TCM
28
Towneley Capital Management
California
– – -10,000 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2